Viremic Non-Progressors (VNPs) are a distinct group of HIV-1 infected individuals who remain asymptomatic for several years (>7 years) and have good preservation of CD4 count without ART treatment but display high viral replication. We recently reported that CD4 central memory preservation along with intact thymic repopulation are key homeostatic mechanism resisting CD4 depletion in VNPs. In this study we attempted to identify gut trafficking potential and virus specific functional attributes that could underlie the paradoxical virus-host equilibrium observed in VNPs.
We analyzed HIV-specific responses in VNPs, Viremic Controllers (VC) and Putative Progressors (PuPs) with recent HIV1 infection. All groups had CD4 count of ?500 cells/µl and had high viral replication except for VCs (Table1). Five different functions, including production of IFN-?, IL-2, TNF-?, MIP-1? and CD107a expression in different memory CD4 and CD8 T cell subsets were evaluated following stimulation of thawed PBMCs with overlapping HIV1 Gag and Env peptides. In addition, ex-vivo immunophenotyping was performed to understand CCR5 (HIV Co-receptor) and integrin ?4?7 (Gut trafficking marker) level on different CD4 and CD8 T cell subsets. Non-parametric one-way ANOVA test was performed on the data.
Our study delineates unique signatures of viremic non-progression where HIV-specific T cell responses in VNPs are dominated by a potent non-cytolytic response enriched for MIP-1? production with concomitantly dampened degranulation ability (CD107a detection; cytolytic potential). VCs who efficiently control viremia, also had robust cytolytic potential. Intriguingly, early response in PuPs shared both these features but lacked Gag-specific CD4 central memory IFN-? responses (CD4 help) compared to both VNP and VC groups. Polyfunctional response observed in VNPs were quantitatively and qualitatively comparable to both VC and immunologically competent (?500 CD4 cells/µl) PuP groups. Additionally, ex-vivo immunophenotyping showed different CD4 subsets had similar CCR5 expression. Intriguingly, in addition to diminished cytolytic potential, VNPs also had significantly reduced frequency of ?4?7 expressing CD8 memory subsets suggesting relatively less trafficking of CTLs in GALT and possibly reduced gut pathology.
Understanding detailed mechanisms underlying the non-cytolytic HIV-specific T cell response mediated non-progression in VNPs may allow immunotherapeutic interventions to achieve functional cure.